Hisun Pharmaceutical and Pfizer launch a JV targeting the Chinese biosimilars market

March 06, 2012 | Analyst Insight

Hisun Pharmaceutical and Pfizer have signed JV framework contract with tentative name Hisun-Pfizer Pharmaceutical with registered capital of $250 million, but a total invested amount of $295 million. Hisun will hold 51% of the...